Anti-CRYAB monoclonal antibody

Pre-made anti-CRYAB monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CRYAB/CRYAB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0616-Ab-1/ GM-Tg-hg-IP0616-Ab-2Anti-Human CRYAB monoclonal antibodyHuman
GM-Tg-rg-IP0616-Ab-1/ GM-Tg-rg-IP0616-Ab-2Anti-Rat CRYAB monoclonal antibodyRat
GM-Tg-mg-IP0616-Ab-1/ GM-Tg-mg-IP0616-Ab-2Anti-Mouse CRYAB monoclonal antibodyMouse
GM-Tg-cynog-IP0616-Ab-1/ GM-Tg-cynog-IP0616-Ab-2Anti-Cynomolgus/ Rhesus macaque CRYAB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0616-Ab-1/ GM-Tg-felg-IP0616-Ab-2Anti-Feline CRYAB monoclonal antibodyFeline
GM-Tg-cang-IP0616-Ab-1/ GM-Tg-cang-IP0616-Ab-2Anti-Canine CRYAB monoclonal antibodyCanine
GM-Tg-bovg-IP0616-Ab-1/ GM-Tg-bovg-IP0616-Ab-2Anti-Bovine CRYAB monoclonal antibodyBovine
GM-Tg-equg-IP0616-Ab-1/ GM-Tg-equg-IP0616-Ab-2Anti-Equine CRYAB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0616-Ab-1/ GM-Tg-hg-IP0616-Ab-2; GM-Tg-rg-IP0616-Ab-1/ GM-Tg-rg-IP0616-Ab-2;
GM-Tg-mg-IP0616-Ab-1/ GM-Tg-mg-IP0616-Ab-2; GM-Tg-cynog-IP0616-Ab-1/ GM-Tg-cynog-IP0616-Ab-2;
GM-Tg-felg-IP0616-Ab-1/ GM-Tg-felg-IP0616-Ab-2; GM-Tg-cang-IP0616-Ab-1/ GM-Tg-cang-IP0616-Ab-2;
GM-Tg-bovg-IP0616-Ab-1/ GM-Tg-bovg-IP0616-Ab-2; GM-Tg-equg-IP0616-Ab-1/ GM-Tg-equg-IP0616-Ab-2
Products NameAnti-CRYAB monoclonal antibody
Formatmab
Target NameCRYAB
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CRYAB monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0616-Ag-1Recombinant multi-species CRYAB/ CMD1II/ CRYA2 protein
    ORF Viral VectorvGMLP002745human CRYAB Lentivirus particle
    ORF Viral VectorpGMLP002745human CRYAB Lentivirus plasmid
    ORF Viral VectorvGMLV000870human CRYAB Lentivirus particle
    ORF Viral VectorpGMLV000870human CRYAB Lentivirus plasmid
    ORF Viral VectorpGMLPm000066mouse Cryab Lentivirus plasmid
    ORF Viral VectorvGMLPm000066mouse Cryab Lentivirus particle


    Target information

    Target IDGM-IP0616
    Target NameCRYAB
    Gene ID1410,12955,25420,710747,479441,101092640,281719,100061921
    Gene Symbol and SynonymsAACRYA,CMD1II,Crya-2,CRYA2,CRYAB,CTPP2,CTRCT16,HEL-S-101,HSPB5,MFM2,P23
    Uniprot AccessionP02511,P23928,P02510
    Uniprot Entry NameCRYAB_HUMAN,CRYAB_RAT,CRYAB_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseBreast Cancer
    Gene EnsemblENSG00000109846
    Target ClassificationN/A

    The target: CRYAB, gene name: CRYAB, also named as CMD1II, CRYA2, CTPP2, CTRCT16, HEL-S-101, HSPB5, MFM2. Mammalian lens crystallins are divided into alpha, beta, and gamma families. Alpha crystallins are composed of two gene products: alpha-A and alpha-B, for acidic and basic, respectively. Alpha crystallins can be induced by heat shock and are members of the small heat shock protein (HSP20) family. They act as molecular chaperones although they do not renature proteins and release them in the fashion of a true chaperone; instead they hold them in large soluble aggregates. These heterogeneous aggregates consist of 30-40 subunits; the alpha-A and alpha-B subunits have a 3:1 ratio, respectively. Two additional functions of alpha crystallins are an autokinase activity and participation in the intracellular architecture. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Alpha-A and alpha-B gene products are differentially expressed; alpha-A is preferentially restricted to the lens and alpha-B is expressed widely in many tissues and organs. Elevated expression of alpha-B crystallin occurs in many neurological diseases; a missense mutation cosegregated in a family with a desmin-related myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2019].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.